Drug intelligence / Profile preview

MAGNA Omega-3

Development stage
Unknown
Lead developer
Magna Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

MAGNA Omega-3 is a dietary supplement developed by Magna Pharmaceuticals, Inc. (Magna Invests) designed to support cardiovascular and cognitive health. Each oral softgel contains 1400 mg of highly concentrated, molecularly distilled fish oil, providing 420 mg of eicosapentaenoic acid (EPA) and 350 mg of docosahexaenoic acid (DHA). These omega-3 fatty acids exert anti-inflammatory and lipid-modulating effects, which contribute to the maintenance of healthy triglyceride levels and overall heart and brain function. The product is sourced from cold-water fish and is molecularly distilled to ensure purity, with testing performed to ensure the absence of pesticides, PCBs, and heavy metals like mercury.

Brand names
MAGNA Omega-3
Other names
MAGNA Omega 3
02

Targets

RARA (Retinoic acid receptor alpha)PPARA (Peroxisome proliferator-activated receptor alpha)PPARG (Peroxisome proliferator-activated receptor gamma)FFAR4 (Free fatty acid receptor 4)

Beyond the preview

Go deeper on MAGNA Omega-3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MAGNA Omega-3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call